3 AI-Driven Medical Device Stocks to Watch in 2025
NVIDIA NVDA cofounded the Medical Open Network for AI ('MONAI') with the world's leading academic medical centers to establish an inclusive community of AI researchers, developing and exchanging best practices for AI in healthcare imaging across academia and enterprise researchers. Additionally, Gen AI powers real-time clinical documentation tools embedded within diagnostic devices, such as Nuance Communications's Dragon Ambient eXperience ('DAX'). These devices transcribe doctor-patient conversations into structured clinical notes, minimizing administrative burden and enhancing documentation accuracy.
Alternatively, agentic AI enables medical devices to act autonomously and make decisions based on real-time data. Agentic AI also supports predictive maintenance in connected medical equipment, such as MRIs and ventilators. This enables fault detection and automated service scheduling, thereby reducing equipment downtime. In the surgical field, AI-guided robotic systems, such as Intuitive Surgical's ISRG da Vinci platform, are integrating agentic AI features to assist with real-time tissue navigation and instrument movement.
Here, we have picked three medical devices stocks, namely Boston Scientific Corporation BSX, Johnson & Johnson JNJ and GE HealthCare Technologies Inc. GEHC, which are likely to perform well in 2025, driven by strong AI adoption.
Rising Demand for Precision and Personalized Medicine: AI enables medical devices to deliver highly individualized diagnostics and treatments. For instance, AI algorithms can analyze patient-specific imaging data or genetic profiles to guide the design of implants, surgical plans, or therapeutic regimens, improving patient outcomes.
Favorable Regulatory Environment: Regulatory oversight for AI in the United States falls under the FDA's Software as a Medical Device (SaMD) segment. Over 700 AI-enabled devices have been approved, which is more than 10 times the number available in 2020. In January, the FDA released a draft guidance on adaptive AI systems, which have reduced uncertainty for developers, encouraging innovation and faster approvals.
Boston Scientific is a major manufacturer of interventional medical devices. The company has been investing in AI to support its devices and improve procedural outcomes. It's HeartLogic is a heart failure diagnostic that utilizes AI to detect worsening heart failure in patients with implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds). The Rhythm AI module in the Rhythmia HDx mapping system can automatically interpret electroanatomical maps to identify arrhythmia circuits, enabling electrophysiologists to target ablation therapy more effectively. Meanwhile, the company's Coronary Advanced Analysis software uses AI to analyze optical coherence tomography images to characterize plaque.
Boston Scientific, carrying a Zacks Rank #2 (Buy) at present, has a projected 2025 sales growth rate of 16.4%, higher than the industry's flat growth. The company has a favorable current cashflow rate of 26.5% against the industry's -2.6%. For 2025, its earnings are expected to grow 15.9%.
Boston Scientific Corporation price | Boston Scientific Corporation Quote
Johnson & Johnson is a healthcare conglomerate with a major MedTech division (Johnson & Johnson MedTech) focused on medical devices and diagnostics. The company employs AI for surgical robotics, digital surgery analytics and imaging. It has developed an ecosystem called Ottava, its next-gen robotic surgery platform, and the Caresurgical/VELYS digital surgery systems, which use data and AI for procedure planning. Its Polyphonic Digital Ecosystem connects operating rooms, allowing surgeons to share live video and data with remote peers. AI in this system helps identify significant events in the surgery video feed for discussion.
Johnson & Johnson, carrying a Zacks Rank #2 at present, has a historical earnings growth rate of 5.5%, higher than the industry's 2.8%. The company has a net margin of 24.4%, outperforming the industry's 18.6%. For 2025, its sales are expected to grow 2.8%.
Johnson & Johnson price | Johnson & Johnson Quote
GE HealthCare is a global leader in medical imaging, diagnostics and healthcare. AI is central to the company's digital strategy, which focuses on its precision care framework. In 2023, it topped the FDA list of AI-enabled medical devices with 80 listed 510(k) clearances or authorizations to date in the United States. Recently, the company has launched CleaRecon DL — an AI-driven solution that enhances cone-beam computed tomography image quality. Also, its Invenia Automated Breast Ultrasound Premium, the latest 3D ultrasound, offers advanced AI and innovative features to drive faster, reproducible supplemental screening and streamline exam readings on patients with dense breasts.
GE HealthCare, carrying a Zacks Rank #3 (Hold) at present, has a projected 2025 sales growth rate of 3.2%, higher than the industry's flat growth. The company has a favorable current cashflow rate of 9.7% against the industry's -2.6%.
GE HealthCare Technologies Inc. price | GE HealthCare Technologies Inc. Quote
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Boston Scientific Corporation (BSX) : Free Stock Analysis Report
Johnson & Johnson (JNJ) : Free Stock Analysis Report
Intuitive Surgical, Inc. (ISRG) : Free Stock Analysis Report
NVIDIA Corporation (NVDA) : Free Stock Analysis Report
GE HealthCare Technologies Inc. (GEHC) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Hilton beats earnings expectations despite modest RevPAR decline
-- Hilton Worldwide Holdings Inc. reported second-quarter earnings that exceeded analyst expectations, with adjusted earnings per share of $2.20 surpassing the consensus estimate of $2.03. Revenue for the quarter came in at $3.14 billion, slightly above the analyst forecast of $3.1 billion. The hotel giant's system-wide comparable RevPAR (revenue per available room) declined 0.5% on a currency neutral basis compared to the same period in 2024, attributed to modest occupancy declines that were partially offset by ADR (average daily rate) gains. Despite this top-line weakness, management and franchise fee revenues increased 7.9% YoY. Hilton's stock edged up 0.6% following the announcement. "We continued to demonstrate the power of our resilient business model as we delivered strong bottom line results in the quarter, even with modestly negative top line performance given holiday and calendar shifts, reduced government spending, softer international inbound business and broader economic uncertainty," said Christopher Nassetta, President & CEO of Hilton. For the full year 2025, Hilton projects adjusted earnings per share between $7.83 and $8.00, compared to the analyst consensus of $7.96. The company expects system-wide RevPAR to be flat to up 2.0% on a comparable and currency neutral basis versus 2024. Hilton's development pipeline reached a record 510,600 rooms as of June 30, up 4% from the previous year. The company added 26,100 rooms to its system during the quarter, resulting in 22,600 net additional rooms and contributing to net unit growth of 7.5% YoY. Related articles Hilton beats earnings expectations despite modest RevPAR decline Clients buying into summer rally, bracing for later pullback, says BofA's Hartnett If Powell goes, does Fed trust go with him? Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
18 minutes ago
- Yahoo
How Taiwan Is Betting Big On AI To Power Its Economy
Taiwan Semiconductor Manufacturing Co. (NYSE:TSM) saw its stock recover some losses on Wednesday after closing lower on Tuesday. This rebound comes as the company continues to benefit from robust demand for artificial intelligence (AI) technologies and Taiwan unveils ambitious plans to bolster its position as a global AI powerhouse. Taiwan's Strategic Push into AI Taiwan has launched its 'Ten Major AI Infrastructure Projects,' an initiative designed to inject over 15 trillion New Taiwan dollars (approximately $510 billion) into its economy by 2040, Reuters reported on Wednesday. This strategic move aims to leverage the island's established strengths in the information and communications technology (ICT) sector and its world-leading semiconductor industry to become a dominant force in the global AI the heart of this initiative are three core technologies identified as strategic pillars: silicon photonics, quantum technology, and AI robotics. Silicon photonics, a key area of focus for Taiwan Semiconductor and other industry leaders, is crucial for integrating chip innovation with the evolving demands of AI. To cultivate a strong local ecosystem for AI robotics, Taiwan has also established the AI Robotics Industry Grand Alliance, with the backing of Foxconn Chairman Young Liu. Furthermore, the government intends to build a comprehensive quantum technology supply chain, enhance sovereign AI capabilities, expand computing infrastructure, and ensure that AI development is balanced across all regions of the island. To accelerate this transformation, the government will invest over 100 billion New Taiwan dollars ($3.08 billion) in AI-focused venture capital, aiming to create 500,000 jobs and establish three world-class research laboratories. Stargate Project Setbacks Trigger Dip Shares of Taiwan Semiconductor and its chipmaking peers, including Nvidia (NASDAQ:NVDA), Advanced Micro Devices (NASDAQ:AMD), Broadcom (NASDAQ:AVGO), and Qualcomm (NASDAQ:QCOM), fell on Tuesday after reports revealed deep internal conflicts between OpenAI's Sam Altman and SoftBank's (OTC:SFTBY) Masayoshi Son derailed the ambitious $500 billion Stargate AI project. The feud stalled progress, slashed the project's scale to one smaller Ohio site, and triggered investor concerns, dragging down semiconductor stocks worldwide. Price Action: TSM stock is trading higher by 1.19% to $237.40 premarket at last check Wednesday. Photo by YAKOBCHUK V via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? TAIWAN SEMICONDUCTOR (TSM): Free Stock Analysis Report This article How Taiwan Is Betting Big On AI To Power Its Economy originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.
Yahoo
18 minutes ago
- Yahoo
Stock Index Futures Climb as U.S. Reaches Trade Deal With Japan, Tesla and Alphabet Earnings Awaited
September S&P 500 E-Mini futures (ESU25) are up +0.39%, and September Nasdaq 100 E-Mini futures (NQU25) are up +0.19% this morning as sentiment got a boost after the U.S. announced a trade deal with Japan. U.S. President Donald Trump said in a post on Truth Social late Tuesday that the U.S. will impose a 15% tariff on Japanese goods, including autos, which is lower than the 25% rate he had previously threatened in a letter to the Japanese government. The deal will also see Japan invest $550 billion into the U.S. The U.S. also struck a deal with the Philippines, setting a 19% tariff on the nation's exports. In addition, President Trump unveiled further details about a pact with Indonesia. More News from Barchart Nvidia Stock Warning: This NVDA Challenger Just Scored a Major Customer This High-Yield Dividend Stock (8.3%) Has Analysts Saying 'Strong Buy' — Should You? Should You Buy the Post-Earnings Dip in Lockheed Martin Stock? Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! Investors now gear up for a deluge of corporate earnings reports, with a particular focus on results from 'Magnificent Seven' companies Tesla and Alphabet. In yesterday's trading session, Wall Street's major indexes closed mixed. IQVIA Holdings (IQV) surged over +17% and was the top percentage gainer on the S&P 500 after the company reported stronger-than-expected Q2 results. Also, Paccar (PCAR) climbed more than +6% and was the top percentage gainer on the Nasdaq 100 after the company posted better-than-expected Q2 results. In addition, D.R. Horton (DHI) jumped over +16% after the homebuilder reported upbeat FQ3 results. On the bearish side, Lockheed Martin (LMT) slumped over -10% and was the top percentage loser on the S&P 500 after the defense contractor posted weaker-than-expected Q2 revenue and cut its full-year EPS guidance. Economic data released on Tuesday showed that the U.S. Richmond Fed manufacturing index unexpectedly fell to an 11-month low of -20 in July, weaker than expectations of -2. Second-quarter corporate earnings season is in full swing, with all eyes today on reports from two of this year's laggards among the Magnificent Seven — Tesla (TSLA) and Alphabet (GOOGL). Investors will also monitor earnings reports from other prominent companies such as T-Mobile US (TMUS), International Business Machines (IBM), ServiceNow (NOW), AT&T (T), Thermo Fisher Scientific (TMO), and Chipotle Mexican Grill (CMG). According to Bloomberg Intelligence, companies in the S&P 500 are expected to post an average +3.2% increase in quarterly earnings for Q2 compared to the previous year, slightly above the pre-season forecast of +2.8%. On the economic data front, investors will focus on U.S. Existing Home Sales data, which is set to be released in a couple of hours. Economists, on average, forecast that June Existing Home Sales will stand at 4.00M, compared to 4.03M in May. U.S. Crude Oil Inventories data will be released today as well. Economists expect this figure to be -1.400M, compared to last week's value of -3.859M. U.S. rate futures have priced in a 95.3% chance of no rate change and a 4.7% chance of a 25 basis point rate cut at next week's policy meeting. In the bond market, the yield on the benchmark 10-year U.S. Treasury note is at 4.381%, up +1.04%. The Euro Stoxx 50 Index is up +1.55% this morning as the trade pact between the U.S. and Japan boosted investor optimism that a U.S.-EU agreement could follow. Automobile stocks led the gains on Wednesday after the U.S.-Japan trade deal boosted investor sentiment on the sector. Healthcare stocks, which are also in the crosshairs of Trump's tariff offensive, climbed as well, receiving an additional boost from upbeat Lonza earnings. Meanwhile, the prospects of an EU-U.S. trade agreement improved after Trump said on Tuesday that EU representatives were scheduled to arrive for trade negotiations on Wednesday. Investors now await the Eurozone's preliminary consumer confidence data for July, due later in the session. Investor focus is also on the European Central Bank's rate-setting meeting on Thursday, with the central bank widely expected to keep the deposit rate unchanged at 2.00% following seven straight cuts. In corporate news, Temenos AG ( surged over +20% after the banking software company lifted its annual earnings guidance. At the same time, Nokia Oyj ( slid more than -6% after cutting its 2025 comparable operating profit guidance. Asian stock markets today closed in the green. China's Shanghai Composite Index (SHCOMP) closed up +0.01%, and Japan's Nikkei 225 Stock Index (NIK) closed up +3.51%. China's Shanghai Composite Index closed just above the flatline today. The benchmark index initially moved sharply higher on trade optimism after the U.S. scheduled a new round of talks with China next week and reached a deal with Japan, but pared most of its gains by the close as investors opted to take profits following the recent rally. Technology stocks, which are closely tied to China-U.S. relations, outperformed on Wednesday. The gains came after U.S. Treasury Secretary Scott Bessent said on Tuesday he would meet his Chinese counterparts in Stockholm next week for talks aimed at extending a tariff truce, signaling continued stabilization in relations after the U.S. recently relaxed chip restrictions and China resumed rare earths exports. Meanwhile, China's Ministry of Commerce said on Wednesday that Minister Wang Wentao and European Union trade commissioner Maros Sefcovic held a 'candid and in-depth' discussion on economic and trade cooperation, along with other issues both sides are facing. Investors are also looking to the country's July Politburo meeting, where policymakers will deliberate on economic policies for the second half of the year. Market participants expect China to introduce additional measures to reduce excess capacity in certain emerging industries, ramping up the so-called anti-involution campaign. In corporate news, WuXi XDC Cayman surged over +8% after the company provided a strong H1 net profit forecast. Japan's Nikkei 225 Stock Index closed sharply higher and hit a one-year high today as the country struck a long-awaited trade deal with the U.S. Automobile stocks rallied on Wednesday after U.S. President Donald Trump announced a deal to set a lower-than-feared 15% tariff on imports from Japan. Industry and government officials familiar with the agreement said the deal also reduces the tariff on Japanese cars and auto parts to 15% from 25%, with autos making up more than a quarter of the country's exports to the U.S. 'We were the first in the world to achieve tariff reductions on autos and auto parts with no quantity limits,' Tokyo's top trade negotiator Ryosei Akazawa said after the latest round of trade talks in Washington. Meanwhile, Capital Economics' Marcel Thieliant said the U.S.-Japan trade deal suggests the Bank of Japan may resume its tightening cycle this year, as it eliminates a key downside risk to Japan's economy. BOJ Deputy Governor Shinichi Uchida said on Wednesday that the central bank will continue pursuing further interest rate hikes, reinforcing rate-hike expectations sparked by news of the trade deal with the U.S. In other news, Japanese daily Mainichi reported on Wednesday that Prime Minister Shigeru Ishiba plans to announce his resignation by the end of August, following the ruling coalition's defeat in Sunday's parliamentary elections. However, Ishiba has denied the report. The Nikkei Volatility Index, which takes into account the implied volatility of Nikkei 225 options, closed down -0.83% to 22.73. Pre-Market U.S. Stock Movers Cal-Maine Foods (CALM) climbed more than +5% in pre-market trading after the company posted upbeat FQ4 results. Texas Instruments (TXN) plunged over -12% in pre-market trading after the semiconductor company issued disappointing Q3 earnings guidance. Enphase Energy (ENPH) slumped more than -7% in pre-market trading after the maker of solar-power inverters provided a tepid Q3 revenue forecast. You can see more pre-market stock movers here Today's U.S. Earnings Spotlight: Wednesday - July 23rd Alphabet (GOOGL), Tesla (TSLA), T-Mobile US (TMUS), IBM (IBM), ServiceNow (NOW), AT&T (T), Thermo Fisher Scientific (TMO), NextEra Energy (NEE), Boston Scientific (BSX), GE Vernova LLC (GEV), Amphenol (APH), CME Group (CME), Fiserv (FI), Moody's (MCO), O'Reilly Automotive (ORLY), General Dynamics (GD), Chipotle Mexican Grill (CMG), Freeport-McMoran (FCX), CSX (CSX), Hilton Worldwide (HLT), TE Connectivity (TEL), United Rentals (URI), Waste Connections (WCN), Crown Castle (CCI), Otis Worldwide (OTIS), Raymond James Financial (RJF), Las Vegas Sands (LVS), Rollins (ROL), Teledyne Technologies (TDY), Northern Trust (NTRS), NVR (NVR), Lennox (LII), SS&Cs (SSNC), Rogers Communications (RCI), Packaging America (PKG), Reliance Steel&Aluminum (RS), Graco (GGG), Annaly Capital Management (NLY), Renaissancere (RNR), SEI (SEIC), Hasbro (HAS), Mr. Cooper (COOP), Globe Life (GL), Molina Healthcare (MOH), EastGroup Properties (EGP), Popular (BPOP), Churchill Downs (CHDN), Quantumscape (QS), Knight-Swift Trans (KNX), Prosperity Bancshares (PB), Lamb Weston Holdings (LW), Taylor Morrison Home (TMHC), Wyndham Hotels (WH), Cadence Bancorp (CADE), Mattel (MAT), Alaska Air (ALK), Essential Properties (EPRT), First American (FAF), Selective (SIGI), Wex (WEX), Meritage (MTH), Sonoco Products (SON), Robert Half (RHI), United Community Banks (UCB), Goosehead Insurance (GSHD), Travel + Leisure Co (TNL), Plexus (PLXS), Viking Therapeutics Inc (VKTX), M/I Homes (MHO), BankUnited (BKU), Banc of California (BANC), ASGN (ASGN), Empire State Realty (ESRT), Oceaneering International (OII), Century Communities (CCS), Solaris Oilfield (SEI), Oxford Lane (OXLC), Stewart Info Services (STC), Getty (GTY), Netstreit (NTST), Veris Residential (VRE), Kaiser (KALU), Live Oak Bancshares Inc (LOB), MaxLinear (MXL), QCR (QCRH), Origin Bancorp (OBK), PROG Holdings (PRG). On the date of publication, Oleksandr Pylypenko did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
